SCOPUS 정보 검색 플랫폼

Breast Disease

Volumn 11, Issue , 2000, Pages 113-124

Emerging antibody-based HER2 (ErbB-2/neu) therapeutics

(5) Krauss, W C a,b Park, J W a,b Kirpotin, D B a,b Hong, K a,b Benz, C C a,b

a UNIVERSITY OF CALIFORNIA (United States)

b CALIFORNIA PACIFIC MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CYTOKINE; DOXORUBICIN; GROWTH INHIBITOR; IMMUNOLIPOSOME; IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4D5; NEW DRUG; NSC 701315; NUCLEIC ACID; OLIGONUCLEOTIDE; PRODRUG; TRASTUZUMAB; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TARGETING; DRUG UPTAKE; EPITHELIUM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; ONCOGENE NEU; PHARMACOKINETICS; PRIORITY JOURNAL; TUMOR CELL; TUMOR XENOGRAFT;

EID: 0033907078 PISSN: 08886008 EISSN: None Source Type: Journal
DOI: 10.3233/BD-1999-11110 Document Type: Article

Times cited : (29)

References (65)

1
- 0008490922
- Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor sub-family: Role as anticancer agents Drugs 2000; in press.
- Noonberg, S.B.¹ Benz, C.C.²

2
- 0028670125
- The biology of erbB-2/neu/HER-2 and its role in cancer
- (1994) Biochim Biophys Acta , vol.1198 , pp. 165-184
- Hynes, N.E.¹ Stern, D.F.²

3
- 0008522393
- ErbB2 overexpression in breast cancer: Biology and clinical translation. Women and Cancer 2000; (in press).
- Benz, C.C.¹ Tripathy, T.²

4
- 0002388547
- Activated oncogenes and putative tumor suppressor genes involved in human breast cancers
- Benz CC, Liu E, eds. Oncogenes and Tumor Suppressor Genes in Human Malignancies. Boston, Kluwer Academic Publishers
- (1993) , pp. 15-60
- Tripathy, D.¹ Benz, C.C.²

5
- 0028205995
- Growth factors and their receptors
- Shapiro CL, Henderson IC, eds. New Directions in Breast Cancer Research and Therapeutics.
- (1994) Hematology/Oncology Clin N Am , vol.8 , pp. 29-50
- Tripathy, D.¹ Benz, C.²

6
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of HER2/neu oncogene
- (1987) Science , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

7
- 0024337144
- Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³

8
- 0025281906
- Overexpression of HER2/neu is associated with poor survival in advanced epithelial ovarian cancer
- (1990) Cancer Res , vol.50 , pp. 4087-4091
- Berchuck, A.¹ Kamel, A.² Whitaker, R.³

9
- 0026098279
- Overexpression of HER2/neu in endometrial cancer is associated with advanced stage disease
- (1991) Am J Obstet Gynecol , vol.164 , pp. 5-21
- Berchuch, A.¹ Rodriguez, G.² Kinney, R.B.³

10
- 0025708183
- P185 neu expression in human lung adenocarcinomas predict shortened survival
- (1990) Cancer Res , vol.50 , pp. 5184-5191
- Kern, J.A.¹ Schwartz, D.A.² Nordberg, J.E.³

11
- 0023829645
- Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of v-erbA homologue.
- (1988) Oncogene , vol.2 , pp. 283-287
- Yokota, J.¹ Yamamoto, T.² Miyajima, N.³

12
- 0024308804
- Amplification, overexpression, and rearrangement of the erbB-2 proto-oncogene in primary human stomach carcinomas
- (1989) Cancer Res , vol.49 , pp. 6605-6609
- Park, J.B.¹ Rhim, J.S.² Park, S.C.³ Kimm, S.W.⁴ Kraus, M.H.⁵

13
- 0028912856
- Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival
- (1995) Int J Pancreatol , vol.17 , pp. 15-21
- Lei, A.¹ Appert, H.E.² Nakata, B.³ Domenico, D.R.⁴ Kim, K.⁵ Howard, J.M.⁶

14
- 0025633808
- Amplification and expression of the c-erbB-2/neu protoncogene in human bladder cancer
- (1990) Mol Carcinog , vol.3 , pp. 254-257
- Zhau, H.E.¹ Zhang, X.² Von Eschenbach, A.C.³

15
- 0025633808
- Expression of c-erbB-2/neu proto-oncogene in human prostatic cancer tissues and cell lines
- (1990) Mol Carcinog , vol.3 , pp. 254-257
- Zhau, H.E.¹ Wan, D.S.² Zhou, J.³ Miller, G.J.⁴ von Eschenbach, A.C.⁵

16
- 0025359146
- Expression of the HER2/neu proto-oncogene in normal human adult and fetal tissues
- (1990) Oncogene , vol.5 , pp. 953-962
- Press, M.F.¹ Cordon-Cardo, C.² Slamon, D.J.³

17
- 0027283498
- Stability of HER-2/neu expression over time and at multiple metastatic sites
- (1993) J Natl Can Inst , vol.85 , pp. 1230-1235
- Niehans, G.A.¹ Singleton, T.P.² Dykoski, D.³ Kiang, D.T.⁴

18
- 0027375130
- Differential responses of human tumor cell lines to anti-p185 HER2 monoclonal antibodies
- (1993) Cancer Immunol Immunother , vol.37 , pp. 255-263
- Lewis, G.D.¹ Figari, I.² Fendly, B.³

19
- 0026729940
- Surface distribution and internalization of erbB-2 proteins
- (1992) Exp Cell Res , vol.202 , pp. 274-280
- Lotti, L.V.¹ Dilazzaro, C.² Frati, L.³ Torrisi, M.R.⁴

20
- 0031440794
- Molecular mechanism of endocytosis
- (1997) Cell , pp. 731-738
- Riezman, H.¹ Woodman, P.G.² van Meer, G.³ Marsh, M.⁴

21
- 0027333415
- Signal-dependent membrane protein trafficking in the endocytic pathway
- (1993) Annu Rev Cell Biol , vol.9 , pp. 129-161
- Trowbridge, I.S.¹ Collawn, J.F.² Hopkins, C.R.³

22
- 0008486660
- Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.
- (1986) Proc Natl Acad Sci , vol.83 , pp. 3825-3834
- Sunada, H.¹ Magun, B.E.² Mendelson, J.³ MacLeod, C.L.⁴

23
- 0026174552
- Characterization of an anti-p185 HER2 monoclonal antibody that stimulated receptor function and inhibits tumor cell growth
- (1991) Growth Regul , vol.37 , pp. 72-82
- Sarup, J.C.¹ Johnson, R.M.² King, K.L.³

24
- 0026360077
- p185(HER2) signal transduction in breast cancer cells
- (1991) J Biol Chem , vol.266 , pp. 14300-14305
- Scott, G.K.¹ Dodson, J.M.² Montgomery, P.³

25
- 0028912598
- Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake
- (1995) Proc Natl Acad Sci , vol.92 , pp. 3353-3357
- Hurwitz, E.¹ Stancovski, I.² Sela, M.³ Yarden, Y.⁴

26
- 0030964090
- Antigen-specific agents in development
- (1997) Semin Oncol , vol.24 , pp. 173-186
- Sznol, M.¹ Holmlund, J.²

27
- 0024478054
- p185(HER2) monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
- (1989) Mol Cell Biol , vol.9 , pp. 1165-1172
- Hudziak, R.M.¹ Lewis, G.D.² Winget, M.³ Fendly, B.M.⁴ Shepard, H.M.⁵ Ullrich, A.⁶

28
- 0025986825
- A monoclonal antibody against the c-erbB2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.
- (1991) Cancer Res , vol.51 , pp. 4575-4580
- Hancock, M.C.¹ Langton, B.C.² Chan, T.³

29
- 0026610881
- Humanization of an anti-p185(HER2) antibody for human cancer therapy
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 4285-4289
- Carter, P.¹ Presta, L.² Gorman, C.M.³

30
- 0029991439
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 737-744
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³

31
- 0032127350
- Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.
- (1998) Cancer Res , vol.58 , pp. 2825-2831
- Baselga, J.¹ Norton, L.² Albanell, J.³ Kim, Y.M.⁴ Mendelsohn, J.⁵

32
- 0000905158
- Efficacy and safety of Herceptin (humanized anti-HER2 anti-body) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherapy for metastatic breast cancer.
- (1998) Proc Amer Soc Clin Oncol , vol.17 , pp. 376
- Cobleigh, M.A.¹ Vogel, C.L.² Tripathy, D.³

33
- 0000405942
- Addition of Herceptin (humanized anti-HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2+/MBC) markedly increases anti-cancer activity: A randomized multinational controlled phase III trial.
- (1998) Proc Amer Soc Clin Oncol , vol.17 , pp. 377
- Slamon, D.¹ Leyland-Jones, B.² Shak, S.³

34
- 0008504723
- Trastuzumab/Herceptin(C), package insert (FDA-approved Sept. 25, 1998), USPI.

35
- 0029918343
- Why toxins! Seminars in cancer biology
- (1996) , vol.7 , pp. 87-95
- Fitzgerald, D.¹

36
- 0026486446
- Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB2 receptor
- (1992) Cancer Res , vol.52 , pp. 6310-6317
- Wels, W.¹ Harwerth, I.M.² Mueller, M.³ Groner, B.⁴ Hynes, N.E.⁵

37
- 0026755810
- Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 5867-5871
- Batra, J.K.¹ Kasprzyk, P.G.² Bird, R.E.³ Pastan, I.⁴ King, C.R.⁵

38
- 0028320586
- In vitro and in vivo activity of a recombinant toxin OLX-209, which targets the erbB2 oncoprotein.
- (1994) Adv Enzymol , vol.34 , pp. 119-128
- Fischer, P.H.¹ Bird, R.E.² Kasprzyk, P.G.³

39
- 9044224400
- Activity of anti-erbB2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB2 gene amplification.
- (1996) Clin Cancer Res , vol.2 , Issue.1 , pp. 75-80
- Kasprzyk, P.G.¹ Sullivan, T.L.² Hunt, J.D.³

40
- 0030031901
- Preclinical testing of an anti-erbB2 recombinant toxin
- (1996) Breast Cancer Res Treat , vol.38 , Issue.1 , pp. 19-25
- King, C.R.¹ Kasprzyk, P.G.² Fischer, P.H.³

41
- 0032526014
- Systemic treatment with a recombinant erbB2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells.
- (1998) Cancer Res , vol.58 , Issue.12 , pp. 2661-2666
- Maurer-Gebhard, M.¹ Schmidt, M.² Azemar, M.³

42
- 0032904481
- Recombinant immunotoxins directed against the c-erbB2/HER2/neu oncogene product: in vivo cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
- (1999) Clin Cancer Res , vol.5 , pp. 865-874
- Rosenblum, M.B.¹ Shawver, L.K.² Marks, J.W.³

43
- 0028959129
- Development of a humanized disulfide stabilized anti-p185 HER2 Fv-β-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.
- (1995) Cancer Res , vol.55 , pp. 63-70
- Rodrigues, M.L.¹ Presta, L.G.² Kotts, C.E.³

44
- 0030727901
- Clinical experience with CD64-directed immunotherapy: An overview
- (1997) Cancer Immunol , vol.45 , pp. 210-215
- Curnow, R.T.¹

45
- 0026604793
- Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene
- (1992) J Exp Med , vol.175 , pp. 217-225
- Shalaby, M.R.¹ Shepard, H.M.² Presta, L.³

46
- 0027388920
- A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16
- (1993) Cancer Res , vol.53 , pp. 94-100
- Weiner, L.M.¹ Holmes, M.² Adams, G.P.³ LaCreta, F.⁴ Watts, P.⁵ Garcia de Palazzo, I.⁶

47
- 0029095589
- Phase II/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpress the proto-oncogene HER2/neu.
- (1995) J Clin Invest , vol.13 , pp. 2281-2292
- Valone, F.H.¹ Kaufman, P.A.² Guyre, P.M.³

48
- 0030858083
- Bispecific antibody-dependent cellular cytotoxicity of HER2/neu overexpressing tumor cells by Fc gamma receptor type 1 expressing effector cells.
- (1997) Cancer Res , vol.57 , Issue.18 , pp. 4008-4014
- Keler, T.¹ Graziano, R.F.² Mandal, A.³

49
- 0842279809
- Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
- (1988) Proc Natl Acad Sci USA , vol.85 , pp. 6949-6953
- Gabizon, A.¹ Papahadjopoulos, D.²

50
- 0026352832
- Sterically stabilized liposomes: Improvements in pharmaco-kinetics and anti-tumor therapeutic efficacy
- (1991) Proc Natl Acad Sci USA , vol.88 , pp. 11460-11464
- Papahadjopoulos, D.¹ Allen, T.² Gabizon, A.³

51
- 0027097957
- Long circulating liposomes: Development and perspectives
- (1992) J Liposome Res , vol.2 , pp. 321-332
- Klibanov, A.L.¹ Huan, L.²

52
- 0026774346
- Sterically stabilized liposomes
- (1992) Biochim Biophys Acta , vol.1113 , pp. 171-199
- Woodle, M.C.¹ Lasic, D.D.²

53
- 0030627930
- Immunoliposomes for cancer treatment
- (1997) Adv Pharmacol , vol.40 , pp. 399-435
- Park, J.W.¹ Hong, K.² Kirpotin, D.B.³ Papahadjopoulos, D.⁴ Benz, C.C.⁵

54
- 0028986610
- Development of anti-p185 HER2 immunoliposomes for cancer therapy
- (1995) Proc Natl Acad Sci USA , vol.92 , pp. 1327-1331
- Park, J.W.¹ Hong, K.² Carter, P.³

55
- 0031021149
- Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro
- (1997) Biochemistry , vol.36 , pp. 66-75
- Kirpotin, D.¹ Park, J.W.² Hong, K.³

56
- 0030778998
- Anti-HER2 immunoliposomes for targeted therapy of human tumors
- (1997) Cancer Lett , vol.118 , pp. 153-160
- Park, J.W.¹ Hong, K.² Kirpotin, D.B.³ Meyer, O.⁴ Papahadjopoulos, D.⁵ Benz, C.C.⁶

57
- 0031023264
- Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
- (1997) FEBS Lett , vol.400 , pp. 233-237
- Hong, K.¹ Zheng, W.W.² Baker A. Papahadjopoulos, D.³

58
- 0032546804
- Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides
- (1998) J Biol Chem , vol.273 , pp. 15621-15627
- Meyer, O.¹ Kirpotin, D.² Hong, K.³

59
- 0001940256
- Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene
- Lasic DD, Papahadjopoulos D, eds. Medical Applications of Liposomes. Amsterdam, Elsevier Science B.V.
- (1998) , pp. 325-345
- Kirpotin, D.B.¹ Park, J.W.² Hong, K.³

60
- 0032432730
- Anti-HER2 immunoliposomes for targeted drug delivery
- (1998) Med Chem Res , vol.8 , pp. 383-391
- Park, J.W.¹ Kirpotin, D.² Hong, K.³

61
- 0023447252
- Lipofection: A highly efficient, lipid mediated DNA transfection procedure
- (1987) Proc Natl Acad Sci USA , vol.84 , pp. 7413-7417
- Flegner, P.L.¹ Gadek, T.R.² Hulm, M.³

62
- 3142714019
- Cationic liposome-mediated RNA transfection
- (1989) Proc Natl Acad Sci USA , vol.86 , pp. 6077-6081
- Malone, R.W.¹ Felgner, P.L.² Verma, I.M.³

63
- 0031041090
- Cationic liposomes as an oligonucleotide carrier: Mechanism of action
- (1997) J Liposome Res , vol.7 , pp. 31-49
- Zelphati, O.¹ Szoka, F.C.²

64
- 0008471905
- Development of liposome- and anti-HER2 immunoliposome-plasmid complexes for gene delivery
- (1997) Proc Amer Assoc Cancer Res , vol.38 , pp. 342
- Park, J.W.¹ Hong, K.² Zheng, W.³ Benz, C.C.⁴ Papahadjopoulos, D.⁵

65
- 0000332782
- Anti-HER2 immunoliposomesribozyme constructs mediate targeted gene transfer and HER2 downmodulation
- (1999) Proc Amer Assoc Cancer Res , vol.40 , pp. 418
- Ren, S.¹ Scott, G.² Zheng, W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.